Cargando…
A study exploring critical pathways in clear cell renal cell carcinoma
Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861490/ https://www.ncbi.nlm.nih.gov/pubmed/24348776 http://dx.doi.org/10.3892/etm.2013.1392 |
_version_ | 1782295648163332096 |
---|---|
author | ZENG, ZISAN QUE, TENGCHENG ZHANG, JIANGE HU, YANLING |
author_facet | ZENG, ZISAN QUE, TENGCHENG ZHANG, JIANGE HU, YANLING |
author_sort | ZENG, ZISAN |
collection | PubMed |
description | Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into the pathogenesis of RCC; however, few studies have investigated RCC at the pathway level to search for the possible pathways involved in clear cell RCC (CCRCC). In this study, gene set enrichment analysis (GSEA) was conducted on microarray datasets from CCRCC tissue. DAVID functional enrichment analysis was performed based on the dysregulated genes that were identified in a meta-analysis performed on the microarray datasets from CCRCC tissue. In GSEA, 17 down- and 12 upregulated pathways coexisted in six datasets. The majority of the upregulated pathways were associated with the immune system. In addition, 32 dysregulated pathways were obtained from DAVID functional enrichment analysis, based on the abnormal genes identified by meta-analysis. This study demonstrated that cross-GSEA is a useful method for exploring the critical pathways involved CCRCC; however, an individual dataset with a small sample may introduce bias. A cross-GSEA based on certain well-designed datasets may be required to further the progress made in this study, following the analysis of its results. |
format | Online Article Text |
id | pubmed-3861490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-38614902013-12-13 A study exploring critical pathways in clear cell renal cell carcinoma ZENG, ZISAN QUE, TENGCHENG ZHANG, JIANGE HU, YANLING Exp Ther Med Articles Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into the pathogenesis of RCC; however, few studies have investigated RCC at the pathway level to search for the possible pathways involved in clear cell RCC (CCRCC). In this study, gene set enrichment analysis (GSEA) was conducted on microarray datasets from CCRCC tissue. DAVID functional enrichment analysis was performed based on the dysregulated genes that were identified in a meta-analysis performed on the microarray datasets from CCRCC tissue. In GSEA, 17 down- and 12 upregulated pathways coexisted in six datasets. The majority of the upregulated pathways were associated with the immune system. In addition, 32 dysregulated pathways were obtained from DAVID functional enrichment analysis, based on the abnormal genes identified by meta-analysis. This study demonstrated that cross-GSEA is a useful method for exploring the critical pathways involved CCRCC; however, an individual dataset with a small sample may introduce bias. A cross-GSEA based on certain well-designed datasets may be required to further the progress made in this study, following the analysis of its results. D.A. Spandidos 2014-01 2013-11-07 /pmc/articles/PMC3861490/ /pubmed/24348776 http://dx.doi.org/10.3892/etm.2013.1392 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles ZENG, ZISAN QUE, TENGCHENG ZHANG, JIANGE HU, YANLING A study exploring critical pathways in clear cell renal cell carcinoma |
title | A study exploring critical pathways in clear cell renal cell carcinoma |
title_full | A study exploring critical pathways in clear cell renal cell carcinoma |
title_fullStr | A study exploring critical pathways in clear cell renal cell carcinoma |
title_full_unstemmed | A study exploring critical pathways in clear cell renal cell carcinoma |
title_short | A study exploring critical pathways in clear cell renal cell carcinoma |
title_sort | study exploring critical pathways in clear cell renal cell carcinoma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861490/ https://www.ncbi.nlm.nih.gov/pubmed/24348776 http://dx.doi.org/10.3892/etm.2013.1392 |
work_keys_str_mv | AT zengzisan astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT quetengcheng astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT zhangjiange astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT huyanling astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT zengzisan studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT quetengcheng studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT zhangjiange studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma AT huyanling studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma |